Latest

THC

This shows a person holding a joint and a glass of scotch.

·November 19, 2025·7 min read

Cannabis Blunts Alcohol Cravings

A randomized, placebo-controlled trial shows that cannabis with active THC reduces immediate alcohol cravings and lowers drinking levels in heavy-drinking young adults. After smoking THC, participants not only drank less, they waited longer before taking the first sip and reported lower urges to drink.

This shows a featured brain and a cannabis leaf.

Featured Neuroscience Psychology

·August 26, 2025·4 min read

High-THC Cannabis Linked to Psychosis and Addiction

A systematic review of nearly 100 studies found that high-THC cannabis products are linked to negative mental health outcomes, particularly psychosis, schizophrenia, and cannabis use disorder. While some therapeutic research hinted at benefits for anxiety and depression, results were inconsistent and often showed potential harm.

Featured Neuroscience Pain

·February 6, 2025·6 min read

How CBD Modulates THC’s Impact on the Brain

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis. Unlike THC, which fully activates the receptor and causes side effects like memory loss and addiction, CBD acts as a modulator, fine-tuning receptor activity.

Featured Genetics Neuroscience Psychology

·December 6, 2024·6 min read

Psychosis Risk Tied to Heavy Cannabis Use and Genetic Factors

Heavy cannabis use and genetic risk for schizophrenia independently contribute to the likelihood of developing psychosis. Researchers used two large datasets to analyze the relationship between cannabis use, schizophrenia polygenic risk scores (PRS), and psychosis.

Featured Genetics Neuroscience Psychology

·October 17, 2024·6 min read

Cannabis Leaves Molecular Marks on DNA Linked to Psychosis

Frequent use of high-potency cannabis leaves unique molecular marks on DNA, particularly affecting genes related to energy and immune function. Researchers found that DNA methylation—an epigenetic modification—differed between frequent cannabis users who had experienced psychosis and those who had not, suggesting a possible genetic link to psychosis risk.

Featured Neurology Neuroscience Psychology

·October 2, 2024·4 min read

Cannabis Pill Reduces Agitation in Alzheimer’s Patients by 30%

A new study reveals that dronabinol, a synthetic form of THC, can reduce agitation in Alzheimer’s patients by 30%. Unlike current medications, dronabinol showed fewer side effects, such as delirium or seizures, making it a safer alternative.

Featured Neuroscience Psychology

·May 13, 2024·5 min read

High-Potency Cannabis Linked to Youth Psychosis

Young individuals who use high-potency cannabis between ages 16 and 18 are twice as likely to experience psychosis by their mid-twenties compared to those who use lower-potency strains. This research utilized data from the Children of the 90s study, tracking thousands of participants from Bristol.

Featured Neuroscience Psychology

·April 10, 2024·7 min read

Cannabis Compound Curbs Anxiety

A new study illuminated the anxiety-reducing potential of d-limonene, a natural component of cannabis, when combined with THC. The research showcases how vaporized d-limonene can mitigate the anxiety and paranoia often induced by THC, opening avenues for safer medicinal and recreational cannabis use.

Featured Genetics Neuroscience Psychology

·March 27, 2024·7 min read

THC Metabolism Could Influence Cannabis Use Disorder Risk

Researchers linked differences in THC metabolism to varying effects of cannabis use and the risk of developing Cannabis Use Disorder (CUD). The study, which included young adults with and without CUD, found that genetic differences in THC-metabolizing enzymes can lead to stronger and longer-lasting effects of cannabis, especially among females who metabolize THC more slowly.

Featured Neuroscience Psychology

·March 12, 2024·5 min read

Delta-8 THC: Rising Use Among Teens Raises Health Concerns

Approximately 11% of 12th-grade students in the U.S. have used delta-8-THC in the past year, a psychoactive substance derived from hemp with effects similar to traditional THC. This analysis is part of the 2023 Monitoring the Future survey, highlighting concerns over the accessibility of delta-8 products to teenagers, especially given the absence of federal age restrictions for purchase.

Featured Neuroscience Psychology

·October 25, 2023·5 min read

Marijuana is A Potential Risk to Teen Brains Predisposed to Schizophrenia

Researchers studied the effects of THC, marijuana's main psychoactive compound, on adolescent mouse brains. The study found THC-induced structural changes in microglia, specialized brain immune cells, possibly aggravating a genetic predisposition to schizophrenia.

This shows a woman with a swirly background.

Featured Neuroscience Psychology

·July 11, 2023·6 min read

Debunking Myths: Cannabis Compound is Not A Psychedelic

Recent research has debunked claims that THC-O-acetate, a cannabinoid compound, has psychedelic effects similar to LSD or psilocybin. The study surveyed nearly 300 participants' experiences with the compound and found no strong evidence to support the supposed psychedelic effect.